NASDAQ:MLAB - Mesa Laboratories Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$206.83 +1.58 (+0.77 %)
(As of 06/20/2018 04:00 PM ET)
Previous Close$205.25
Today's Range$202.14 - $211.55
52-Week Range$122.35 - $211.55
Volume49,100 shs
Average Volume19,279 shs
Market Capitalization$770.87 million
P/E Ratio33.47
Dividend Yield0.32%
Mesa Laboratories logoMesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling, and semiconductor industries. Its Biological Indicators segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and testing services. This segment also distributes chemical indicators that are used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide, and radiation. The company's Cold Chain Monitoring segment offers systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and various other laboratory and industrial environments; and parameter monitoring services for products in a cold chain. Its Cold Chain Packaging segment offers packaging development consulting services and thermal packaging products. The company markets its products through distributors in the United States, Europe, Africa, Asia, South America, Australia, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments


Debt-to-Equity Ratio0.45
Current Ratio1.85
Quick Ratio1.32


Trailing P/E Ratio33.47
Forward P/E Ratio30.24
P/E GrowthN/A

Sales & Book Value

Annual Sales$96.18 million
Price / Sales8.19
Cash Flow$8.8768 per share
Price / Cash23.30
Book Value$26.26 per share
Price / Book7.88


EPS (Most Recent Fiscal Year)$6.18
Net Income$-2,960,000.00
Net Margins-3.08%
Return on Equity12.93%
Return on Assets7.66%


Outstanding Shares3,810,000

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories announced a quarterly dividend on Wednesday, April 4th. Investors of record on Thursday, May 31st will be paid a dividend of $0.16 per share on Friday, June 15th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date is Wednesday, May 30th. View Mesa Laboratories' Dividend History.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) issued its quarterly earnings data on Tuesday, June, 5th. The medical instruments supplier reported $1.08 EPS for the quarter, beating the Zacks' consensus estimate of $0.84 by $0.24. The medical instruments supplier had revenue of $26.88 million for the quarter, compared to analysts' expectations of $25.40 million. Mesa Laboratories had a positive return on equity of 12.93% and a negative net margin of 3.08%. View Mesa Laboratories' Earnings History.

Who are some of Mesa Laboratories' key competitors?

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the folowing people:
  • Mr. Gary M. Owens, CEO, Pres & Director (Age 50)
  • Mr. John V. Sakys, Chief Financial & Chief Accounting Officer, Sec. and Treasurer (Age 49)
  • Mr. Bryan T. Leo, Sr. VP of Operations
  • Mr. Garrett Krushefski, Sr. VP of Operations
  • Ms. Helene R. Leone, Gen. Counsel

Has Mesa Laboratories been receiving favorable news coverage?

Media headlines about MLAB stock have trended somewhat positive on Wednesday, according to Accern. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Mesa Laboratories earned a news impact score of 0.07 on Accern's scale. They also assigned media coverage about the medical instruments supplier an impact score of 46.90 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.01%), Victory Capital Management Inc. (4.47%), Kayne Anderson Rudnick Investment Management LLC (3.35%), Nine Ten Capital Management LLC (2.40%), Thomson Horstmann & Bryant Inc. (2.35%) and King Luther Capital Management Corp (1.18%). Company insiders that own Mesa Laboratories stock include David M Kelly, Glenn E Adriance, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks and Robert V Dwyer. View Institutional Ownership Trends for Mesa Laboratories.

Which institutional investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including King Luther Capital Management Corp, Victory Capital Management Inc., Allianz Asset Management GmbH, Allianz Asset Management GmbH, Teton Advisors Inc., Nine Ten Capital Management LLC and PNC Financial Services Group Inc.. Company insiders that have sold Mesa Laboratories company stock in the last year include H Stuart Campbell, John Bradley Schmieder, John James Sullivan and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.

Which institutional investors are buying Mesa Laboratories stock?

MLAB stock was purchased by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, BlackRock Inc., Stifel Financial Corp, Comerica Bank, UBS Group AG, Cambridge Investment Research Advisors Inc., Schwab Charles Investment Management Inc. and Royal Bank of Canada. View Insider Buying and Selling for Mesa Laboratories.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $206.83.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $770.87 million and generates $96.18 million in revenue each year. The medical instruments supplier earns $-2,960,000.00 in net income (profit) each year or $6.18 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]

MarketBeat Community Rating for Mesa Laboratories (MLAB)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  122 (Vote Outperform)
Underperform Votes:  103 (Vote Underperform)
Total Votes:  225
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.